日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary

索托拉西布与多西他赛治疗既往接受过治疗的KRAS G12C突变型非小细胞肺癌:简明扼要的总结

de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J; Ramalingam, Suresh S; Dooms, Christophe; Lindsay, Colin R; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Björn; Waterhouse, David; Paz-Ares, Luis

Sotorasib with panitumumab in chemotherapy-refractory KRAS(G12C)-mutated colorectal cancer: a phase 1b trial

Sotorasib联合帕尼单抗治疗化疗难治性KRAS(G12C)突变型结直肠癌:一项1b期试验

Kuboki, Yasutoshi; Fakih, Marwan; Strickler, John; Yaeger, Rona; Masuishi, Toshiki; Kim, Edward J; Bestvina, Christine M; Kopetz, Scott; Falchook, Gerald S; Langer, Corey; Krauss, John; Puri, Sonam; Cardona, Panli; Chan, Emily; Varrieur, Tracy; Mukundan, Lata; Anderson, Abraham; Tran, Qui; Hong, David S

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

针对脂蛋白 (a) 的新型 siRNA 的临床前开发和 1 期试验

Michael J Koren #, Patrick Maurice Moriarty, Seth J Baum, Joel Neutel, Martha Hernandez-Illas, Howard S Weintraub, Monica Florio #, Helina Kassahun, Stacey Melquist, Tracy Varrieur, Saptarsi M Haldar, Winnie Sohn, Huei Wang, Mary Elliott-Davey, Brooke M Rock, Tao Pei, Oliver Homann, Jennifer Hellawe